These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 11495027

  • 1. T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
    Hervás-Stubbs S, Lasarte JJ, Sarobe P, Vivas I, Condreay L, Cullen JM, Prieto J, Borrás-Cuesta F.
    J Hepatol; 2001 Jul; 35(1):105-11. PubMed ID: 11495027
    [Abstract] [Full Text] [Related]

  • 2. Induction of antibodies to the PreS region of surface antigens of woodchuck hepatitis virus (WHV) in chronic carrier woodchucks by immunizations with WHV surface antigens.
    Lu M, Klaes R, Menne S, Gerlich W, Stahl B, Dienes HP, Drebber U, Roggendorf M.
    J Hepatol; 2003 Sep; 39(3):405-13. PubMed ID: 12927927
    [Abstract] [Full Text] [Related]

  • 3. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S, Roneker CA, Tennant BC, Korba BE, Gerin JL, Cote PJ.
    Intervirology; 2002 Sep; 45(4-6):237-50. PubMed ID: 12566706
    [Abstract] [Full Text] [Related]

  • 4. Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine.
    D'Ugo E, Kondili LA, Canitano A, Catone S, Giuseppetti R, Gallinella B, Palmieri G, Orobello S, Argentini C, Glück R, Rapicetta M.
    Vaccine; 2007 Jun 21; 25(26):4895-902. PubMed ID: 17531355
    [Abstract] [Full Text] [Related]

  • 5. Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.
    Glebe D, Lorenz H, Gerlich WH, Butler SD, Tochkov IA, Tennant BC, Cote P, Menne S.
    J Virol; 2009 Feb 21; 83(4):1579-91. PubMed ID: 19052077
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.
    Zhou T, Guo JT, Nunes FA, Molnar-Kimber KL, Wilson JM, Aldrich CE, Saputelli J, Litwin S, Condreay LD, Seeger C, Mason WS.
    J Virol; 2000 Dec 21; 74(24):11754-63. PubMed ID: 11090175
    [Abstract] [Full Text] [Related]

  • 7. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Cote PJ, Korba BE, Butler SD, George AL, Tochkov IA, Delaney WE, Xiong S, Gerin JL, Tennant BC.
    Antimicrob Agents Chemother; 2005 Jul 21; 49(7):2720-8. PubMed ID: 15980342
    [Abstract] [Full Text] [Related]

  • 8. Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide.
    Frank I, Budde C, Fiedler M, Dahmen U, Viazov S, Lu M, Dittmer U, Roggendorf M.
    J Virol; 2007 Jul 21; 81(13):7156-63. PubMed ID: 17459928
    [Abstract] [Full Text] [Related]

  • 9. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Jacob JR, Korba BE, Cote PJ, Toshkov I, Delaney WE, Gerin JL, Tennant BC.
    Antiviral Res; 2004 Aug 21; 63(2):115-21. PubMed ID: 15302140
    [Abstract] [Full Text] [Related]

  • 10. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF, Cote PJ, Jacob JR, Toshkov IA, Hornbuckle WE, Baldwin BH, Wells FV, Chu CK, Gerin JL, Tennant BC, Korba BE.
    Hepatology; 2001 Jan 21; 33(1):254-66. PubMed ID: 11124844
    [Abstract] [Full Text] [Related]

  • 11. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.
    Lu M, Hilken G, Kruppenbacher J, Kemper T, Schirmbeck R, Reimann J, Roggendorf M.
    J Virol; 1999 Jan 21; 73(1):281-9. PubMed ID: 9847331
    [Abstract] [Full Text] [Related]

  • 12. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Le Guerhier F, Pichoud C, Jamard C, Guerret S, Chevallier M, Peyrol S, Hantz O, King I, Trépo C, Cheng YC, Zoulim F.
    Antimicrob Agents Chemother; 2001 Apr 21; 45(4):1065-77. PubMed ID: 11257017
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
    Korba BE, Cote P, Hornbuckle W, Schinazi R, Gerin JL, Tennant BC.
    Antiviral Res; 2000 Jan 21; 45(1):19-32. PubMed ID: 10774587
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12.
    García-Navarro R, Blanco-Urgoiti B, Berraondo P, Sánchez de la Rosa R, Vales A, Hervás-Stubbs S, Lasarte JJ, Borrás F, Ruiz J, Prieto J.
    J Virol; 2001 Oct 21; 75(19):9068-76. PubMed ID: 11533170
    [Abstract] [Full Text] [Related]

  • 20. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
    Korba BE, Cote P, Hornbuckle W, Schinazi R, Gangemi JD, Tennant BC, Gerin JL.
    Antivir Ther; 2000 Jun 21; 5(2):95-104. PubMed ID: 10971862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.